Business

Canadabis Capital Expands into European Market with EU-GMP Partners

Canadabis Capital Expands into European Market with EU-GMP Partners Canada NewsWire ...

articleCanadabis Capital, Inc.May 7, 20244/company/canadabis-capital-inc/news/canadabis-capital-expands-into-european-market-with-eu-gmp-partners
Canadabis Capital Expands into European Market with EU-GMP Partners

About this update from Canadabis Capital, Inc.

[{"type":"text","content":"\n \n \n \n Canadabis Capital Expands into European Market with EU-GMP Partners\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n CALGARY, AB\n \n \n ,\n \n \n May 7, 2024\n \n \n /CNW/ - Canadabis Capital (TSXV: CANB) with Sub Stigma Grow, a leading Canadian cannabis company, is pleased to announce its strategic expansion into the European market through a significant distribution agreement. This marks a pivotal moment in Stigma Grows history, as the company's innovative products will now be introduced to international markets.\n \n \n \n \n \n \n \n \n \n Under this new agreement, Stigma Grow will be distributing its high-quality cannabis products in several key European countries, including\n \n Portugal\n \n ,\n \n Germany\n \n , and\n \n Israel\n \n , among others. This move represents a significant milestone for Stigma Grow as it continues to grow its global presence and deliver its cutting edge products to new audiences.\n \n \n \"We are thrilled to announce our entry into the European market through this EU-GMP agreement,\" said\n \n Travis McIntyre\n \n , CEO of Canadabis Capital. \"This expansion represents a major step forward for our company and underscores our commitment to bringing our cutting-edge products to consumers worldwide.\"\n \n \n With a reputation for excellence and a track record of innovation, Stigma Grow is well-positioned to make a significant impact in the European cannabis market. The company's products are known for their quality, consistency, and effectiveness, and have garnered a loyal following in\n \n Canada\n \n and beyond.\n \n \n \"We believe that our products have the potential to transform the cannabis industry in\n \n Europe\n \n ,\" added Mcintyre. \"We are excited to work with our partners to bring Stigma Grow's unique offerings to customers in\n \n Portugal\n \n ,\n \n Germany\n \n ,\n \n Israel\n \n , and other European markets. This agreement comes at a time when the world is opening up to Cannabis and we are just getting started.\"\n \n \n \...

More updates from Canadabis Capital, Inc.